Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study.
Author | |
---|---|
Abstract |
:
We examined the cardiovascular risk of abatacept compared with tumor necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis with and without diabetes mellitus (DM). |
Year of Publication |
:
2018
|
Journal |
:
Journal of the American Heart Association
|
Volume |
:
7
|
Issue |
:
3
|
Date Published |
:
2018
|
URL |
:
http://jaha.ahajournals.org/cgi/pmidlookup?view=long&pmid=29367417
|
DOI |
:
10.1161/JAHA.117.007393
|
Short Title |
:
J Am Heart Assoc
|
Download citation |